CareDx
Launch date
Employees
Market cap
$1.6b
Enterprise valuation
$1.4b (Public information from Sep 2024)
Share price
$29.88 CDNA
Brisbane California (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 192m | 296m | 322m | 280m | 325m | 347m | 388m |
% growth | 51 % | 54 % | 9 % | (13 %) | 16 % | 7 % | 12 % |
EBITDA | (16.2m) | (29.8m) | (77.3m) | 13.7m | 12.6m | 22.3m | 40.8m |
% EBITDA margin | (8 %) | (10 %) | (24 %) | 5 % | 4 % | 6 % | 11 % |
Profit | (18.7m) | (30.7m) | (76.6m) | (190m) | (42.3m) | (36.7m) | (6.5m) |
% profit margin | (10 %) | (10 %) | (24 %) | (68 %) | (13 %) | (11 %) | (2 %) |
EV / revenue | 18.6x | 6.9x | 1.0x | 1.5x | 5.0x | 4.7x | 4.2x |
EV / EBITDA | -220.0x | -68.8x | -4.1x | 30.2x | 129.1x | 72.8x | 39.8x |
R&D budget | 48.9m | 76.5m | 90.4m | 81.9m | - | - | - |
R&D % of revenue | 25 % | 26 % | 28 % | 29 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $5.0m | Series C | |
N/A | $14.8m | Series C | |
$20.0m | Series D | ||
$26.5m | Debt | ||
N/A | $25.0m | Series F | |
$14.4m | Series F | ||
N/A | N/A | IPO | |
N/A | $22.2m | Post IPO Equity | |
N/A | $25.0m | Post IPO Debt | |
Total Funding | $79.2m |
Recent News about CareDx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by CareDx
EditACQUISITION by United Therapeutics Oct 2023
ACQUISITION by CareDx Dec 2015
ACQUISITION by CareDx Apr 2019
ACQUISITION by CareDx Jul 2023
ACQUISITION by CareDx Nov 2021